Marianne M. Helbling
Papers
1
Total Citations
124
H-Index
1
About
Marianne M. Helbling is a pioneering figure in the development of advanced 3D cell culture technologies for drug discovery and personalized medicine. Her research centers on scaffold-free spherical tumor microtissues, high-throughput drug sensitivity testing, and the automation of complex biological assays. Helbling’s most influential work, the 2011 paper “Towards automated production and drug sensitivity testing using scaffold‐free spherical tumor microtissues,” has garnered 124 citations and laid critical groundwork for translating 3D culture systems from academic labs into industrial applications. She recognized that while the biological relevance of 3D models was well-established, their adoption was hindered by a lack of reliable, scalable production methods. By pioneering automated platforms for generating uniform microtissues and integrating them with drug sensitivity assays, Helbling directly addressed this bottleneck. Her contributions have enabled more physiologically relevant cancer drug testing, reducing reliance on traditional 2D cultures and improving predictive accuracy. This work has profound implications for both pharmaceutical development and personalized oncology, positioning Helbling as a key innovator in bridging the gap between tissue engineering and high-throughput screening.
Research Focus
Key Achievements
Top Papers
- 1